Serum growth factor following primary tumor removal and the inhibition of its production by preoperative therapy.

Fisher, B; Saffer, E; Gunduz, N; Coyle, J; Rudock, C

Fisher, B; Saffer, E; Gunduz, N; Coyle, J; Rudock, C.

Affiliation

Fisher B; University of Pittsburgh, Pennsylvania 15261.

Prog Clin Biol Res ; 354A: 47-60, 1990.

Article in En | MEDLINE | ID: mdl-2147283

Subject(s)

Growth Substances/blood; Neoplasms, Experimental/blood; Neoplasms, Experimental/therapy; Preoperative Care/methods; Animals; Buserelin/analogs & derivatives; Buserelin/therapeutic use; Combined Modality Therapy; Culture Media; Cyclophosphamide/therapeutic use; Female; Goserelin; Growth Substances/biosynthesis; In Vitro Techniques; Mice; Tamoxifen/therapeutic use; Tritium

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Preoperative Care / Growth Substances / Neoplasms, Experimental Limits: Animals Language: En Journal: Prog Clin Biol Res Year: 1990 Document type: Article

Search on Google

Add to My VHL

XML

PubMed Links